poisar

Stocks · News reference

8-K filing — CENTENE CORP (CNC)

SEC EDGARSEC EDGAR

Filed: 2026-09-16 AccNo: 0001071739-26-000172 Size: 156 KB Item 7.01: Regulation FD Disclosure

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet

    Centene Corporation has significantly improved its financial position by generating nearly $8 billion in operating cash flow in the first half of 2026 and reducing its debt-to-capital ratio to 41.6% through $1.3 billion in senior note repurchases. The company monetized $1 billion in Part D receivables to support debt reduction while maintaining financial flexibility amid Medicaid payment timing swings.

  2. Zacks Investment ResearchNa

    Can Centene Sustain Its Turnaround Amid Membership Pressure?

    Centene Corporation reported Q2 2026 adjusted EPS of $2.51, marking a significant recovery from a loss a year prior, driven by improved medical cost trends and better execution. The company expects Medicaid membership to decline 8%-9% in 2026, but profitability improvements in Marketplace and Medicare segments, combined with higher Medicaid rates and cost initiatives, support continued recovery. CNC reaffirmed its 2026 adjusted EPS guidance above $4.80.